Japan Medical Devices Market Report and Forecast 2025-2034

The Japan medical devices market was valued at USD 47.10 Billion in 2024, driven by advanced healthcare infrastructure, high R&D capabilities, and strong regulatory standards that ensure quality and safety across the region. It is expected to grow at a CAGR of 5.60% during the forecast period of 2025-2034 and attain a market value of USD 81.22 Billion by 2034.

Japan’s reputation for precision engineering and technological innovation further strengthens the development and global competitiveness of medical equipment produced in the country. Devices made in Japan are often characterized by their accuracy, reliability, and high-quality manufacturing, which has made them highly sought after in international markets. The country’s focus on producing devices that cater to both the domestic and global demand for advanced medical solutions will continue to fuel market expansion during the forecast period.

Japan Medical Devices Market Overview

Medical devices are essential tools in Japan’s healthcare system, supporting diagnosis, treatment, and patient monitoring across various specialties. With a rapidly aging population and rising chronic conditions such as cardiovascular diseases and diabetes, the demand for advanced, minimally invasive, and home-care devices is increasing. These technologies improve patient outcomes, reduce hospital stays, and enhance quality of life. Japan’s focus on healthcare innovation and digital integration further underscores the critical need for medical devices to meet evolving public health challenges. The market is expected to grow at a CAGR of 5.60% during the forecast period of 2025-2034 and attain a market value of USD 81.22 Billion by 2034.

Japan Medical Devices Market Growth Drivers

Launch of Innovative Devices to Drive Market Expansion

Rising cardiovascular disease prevalence and demand for improved surgical solutions are key drivers in Japan’s medical device market. For instance, in May 2024, Teijin Limited, in collaboration with Fukui Tateami Co., Ltd and Osaka Medical and Pharmaceutical University, announced the launch of SYNFOLIUM®, a new cardiovascular surgical patch for congenital heart disease. This innovative product’s tissue integration and growth adaptability features are expected to enhance treatment outcomes, stimulating market growth throughout the forecast period.

Strategic Healthcare Acquisitions to Enhance Japan Medical Devices Market Demand

Expanding healthcare infrastructure and increasing demand for cardiovascular devices are fueling market consolidation in Japan. For instance, in March 2025, Tokyo-based ORIX Corporation acquired Apex Holdings Co., Ltd, a prominent cardiovascular device distributor serving major hospitals. This acquisition strengthens ORIX’s healthcare portfolio, enabling improved procurement and sales efficiency. It is set to boost market development and elevate the overall value of Japan’s medical device sector during the forecast period.

Japan Medical Devices Market Trends

The market is advancing through material innovation and strategic overseas manufacturing investments.

Adoption of Innovative Materials to Enhance Market Competitiveness

Advancements in material science and increasing demand for high-performance medical devices are propelling Japan’s medical device market. For instance, in February 2025, Tanaka Precious Metal Technologies, a subsidiary of Tanaka Holdings Co., Ltd, announced the launch of its Visi-Fine® series. This new line of highly radiopaque precious metal materials, including platinum (Pt) alloy wire, is designed for medical device components requiring clear visibility under imaging. The introduction of Visi-Fine® is expected to enhance the performance and safety of medical devices, thereby contributing to market growth in the forecast period.

Investments into Medical Device Manufacturing to Enhance Market Value

In July 2024, Nipro Medical Corp., headquartered in Osaka, Japan, announced a USD 397.8 million investment to establish a new manufacturing facility in Greenville, North Carolina. This facility aims to produce advanced medical devices for patients with diabetes and chronic kidney disease, creating over 232 jobs. The expansion enhances Nipro's U.S. presence, improving supply chain efficiency and supporting local healthcare needs. This strategic move is expected to bolster Nipro's market share and contribute to the company's growth.

Japan Medical Devices Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

• Respiratory Devices
• Nebulizers
• Humidifiers
• Oxygen Concentrators
• Positive Airway Pressure Devices
• Ventilators
• Gas Analyzers
• Capnographs
• Others
• Cardiology Devices
• Diagnostic and Monitoring Devices
• Electrocardiogram (ECG)
• Remote Cardiac Monitoring Devices
• Others
• Therapeutic and Surgical Devices
• Stents
• Catheters
• Grafts
• Heart Valves
• Others
• Orthopedic Devices
• Replacement Devices
• Bone Fixation Devices
• Orthobiologics
• Braces
• Others
• Diagnostic Imaging Devices
• X-Ray Machines
• MRI Scanners
• CT Scanners
• Ultrasound Systems
• Nuclear Imaging Devices
• Others
• Endoscopy Devices
• Rigid Endoscopy Devices
• Flexible Endoscopy Devices
• Capsule Endoscopy Devices
• Disposable Endoscopy Devices
• Robot Assisted Endoscopy Devices
• Endoscopy Visualization Component
• Operative Devices
• Others
• Ophthalmology Devices
• Optical Coherence Tomography Scanners
• Fundus Cameras
• Perimeters/Visual Field Analyzers
• Autorefractors and Keratometers
• Slit Lamps
• Wavefront Aberrometers
• Optical Biometry Systems
• Corneal Topography Systems
• Specular Microscopes
• Retinoscopes
• Others
• Others

Market Breakup by Application

• Cardiology
• Neurology
• Orthopedics
• Diabetes Care
• Respiratory
• Ophthalmology
• Oncology
• Respiratory
• Others

Market Breakup by End User

• Hospitals
• Specialty Clinics
• Homecare Settings
• Ambulatory Surgical Centers
• Others

Japan Medical Devices Market Share

Cardiology to Account for a Significant Market Share in the Segmentation by Application

Cardiovascular diseases (CVDs) remain a significant health concern in Japan, particularly due to the nation's aging population. In 2021, Japan reported 371,917 deaths attributed to CVDs, highlighting their substantial impact on public health. While age-adjusted mortality rates have shown a declining trend, the crude mortality rate for heart disease has been increasing annually, reflecting the demographic shift towards an older population. The prevalence of heart failure is projected to reach 1.3 million by 2030, underscoring the growing burden of chronic cardiovascular conditions. These trends emphasize the critical need for advanced cardiovascular care and the development of innovative medical devices to address the evolving healthcare demands in Japan.

Leading Players in the Japan Medical Devices Market

The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Medtronic plc

Headquartered in Dublin, Ireland, and founded in 1949, Medtronic plc is one of the world’s largest medical device companies. It operates a significant presence in Japan, offering innovative technologies across cardiovascular, diabetes, neurological, and surgical sectors. Medtronic Japan delivers advanced solutions such as pacemakers, insulin pumps, and spinal implants, aligned with the country’s growing need for chronic disease management and minimally invasive procedures. The company actively collaborates with Japanese healthcare providers to support patient-centric innovations and improve clinical outcomes.

Johnson & Johnson MedTech

Johnson & Johnson MedTech, a division of the U.S.-based Johnson & Johnson established in 1886, has a robust footprint in Japan. Headquartered in New Brunswick, New Jersey, it offers a diverse medical devices portfolio including orthopedics, surgical technologies, cardiovascular care, and vision products. In Japan, the company operates through Ethicon, DePuy Synthes, and Biosense Webster, providing cutting-edge solutions that cater to the country's aging population and rising demand for minimally invasive surgery and interventional technologies.

Fresenius Medical Care AG & Co.

Fresenius Medical Care AG & Co., headquartered in Bad Homburg, Germany, was founded in 1996 and is a global leader in dialysis care and renal technologies. In Japan, the company provides comprehensive dialysis products and services, including hemodialysis machines, dialyzers, and related therapies. Its operations align with Japan’s high prevalence of end-stage renal disease. Fresenius continues to invest in advanced treatment solutions and local partnerships, ensuring efficient patient care and contributing to the nation’s renal healthcare infrastructure.

Abbott

Abbott, a U.S.-based healthcare company established in 1888 and headquartered in Abbott Park, Illinois, maintains a strong presence in Japan’s medical device market. Its diverse product range includes cardiovascular devices, diagnostics, diabetes care, and neuromodulation technologies. Abbott Japan is well known for its innovations in heart failure management, glucose monitoring systems like FreeStyle Libre, and implantable devices. With a focus on preventive care and disease monitoring, the company addresses Japan’s aging demographic and growing burden of chronic diseases.

Other key players in the market include GE Healthcare, Koninklijke Philips N.V., Siemens Healthcare GmbH, and 3M Company, among others.

Key Questions Answered in the Japan Medical Devices Market

• What was the Japan medical devices market value in 2024?
• What is the Japan medical devices market forecast outlook for 2025-2034?
• What are the major factors aiding the Japan medical devices market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major Japan medical devices market trends?
• Which product will lead the market segment?
• Which application will lead the market segment?
• Which end user will lead the market segment?
• Who are the key players involved in the Japan medical devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.